|
|
Article: Thrombus Aspiration with Medtronic's Export Catheter May Improve Outcomes for Heart Attack Patients.
- Article from:
- Heart Disease Weekly
- Article date:
- April 19, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc. (NYSE:MDT), before implanting a stent in patients suffering a specific kind of heart attack, "results in excellent clinical outcomes," at one year, according to new data released at the American College of Cardiology (ACC) meeting (see also Medtronic, Inc.).
Findings from TAPAS-II suggest that thrombus aspiration is feasible and safe and has potential benefits for most patients with non-ST-segment-elevation myocardial infarction (NSTEMI) - heart attacks not distinguished by particular electrocardiogram (ECG) features. For treatment purposes, heart attacks are ...